The study was a cross-sectional prospective
cohort investigation. The study is part of a randomized
clinical trial to test the effectiveness of oral care
with 0.12% chlorhexidine in decreasing VAP in critically
ill children. In the clinical trial, use of 0.12%
chlorhexidine did not significantly modify the incidence
of VAP in a sample of children.